NCT00478283

Brief Summary

RATIONALE: A patient's age, health, and ability to perform daily activities may affect which treatment options are offered by doctors to older and/or frail women with breast cancer. PURPOSE: This clinical trial is studying the views and attitudes of oncologists and geriatricians on the use of chemotherapy and hormone therapy in treating older and/or frail women with breast cancer.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Dec 2006

Shorter than P25 for not_applicable breast-cancer

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2006

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 24, 2007

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
Last Updated

February 9, 2010

Status Verified

February 1, 2010

Enrollment Period

10 months

First QC Date

May 23, 2007

Last Update Submit

February 5, 2010

Conditions

Breast Cancer

Keywords

breast cancer

Outcome Measures

Primary Outcomes (3)

  • Attitudes and perspectives of health professionals

  • Homogeneity of treatment recommendations

  • Relative impact of chronological age, baseline health, and functional status on treatment recommendations

Interventions

survey administrationOTHER

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Participants must meet 1 of the following criteria: * Oncologist: * Must have been in practice ≥ 2 years * Must have ≥ 25 postmenopausal breast cancer patients on adjuvant hormonal therapy * Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA * Geriatrician: * Must have been in practice ≥ 2 years * Must be a general practitioner, family practitioner, internal medicine specialist, or geriatrician and received a certificate of added qualification in geriatric medicine and/or treating at least 5 postmenopausal patients who have a history of breast cancer or are currently undergoing treatment for breast cancer * Cannot work for an advertising agency, market research company, manufacturer or distributor of pharmaceutical products, a pharmacy, drug store, or the FDA PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Arti Hurria, MD

    City of Hope Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Purpose
HEALTH SERVICES RESEARCH
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 23, 2007

First Posted

May 24, 2007

Study Start

December 1, 2006

Primary Completion

October 1, 2007

Study Completion

October 1, 2007

Last Updated

February 9, 2010

Record last verified: 2010-02